Improving the management and outcome in haemolytic disease of the foetus and newborn
- PMID: 24120585
- PMCID: PMC3827389
- DOI: 10.2450/2013.0147-13
Improving the management and outcome in haemolytic disease of the foetus and newborn
Comment on
-
Neonatal outcomes of pregnancies affected by haemolytic disease of the foetus and newborn and managed with intrauterine transfusion: a service evaluation.Blood Transfus. 2013 Oct;11(4):548-52. doi: 10.2450/2013.0288-12. Epub 2013 Jul 19. Blood Transfus. 2013. PMID: 24120586 Free PMC article.
References
-
- Stockman JA., III Overview of the state of the art of Rh disease: history, current clinical management, and recent progress. J Pediatr Hematol Oncol. 2001;23:385–93. - PubMed
-
- Bowman J. Thirty-five years of Rh prophylaxis. Transfusion. 2003;43:1661–6. - PubMed
-
- Moise KJ., Jr Management of rhesus alloimmunization in pregnancy. Obstet Gynecol. 2008;112:164–76. - PubMed
-
- Smits-Wintjens VE, Walther FJ, Lopriore E. Rhesus haemolytic disease of the newborn: Postnatal management, associated morbidity and long-term outcome. Semin Fetal Neonatal Med. 2008;13:265–71. - PubMed
-
- Koelewijn JM. Detection and prevention of pregnancy immunisation: The OPZI study Faculty of Medicine. University of Amsterdam; The Netherlands: 2009.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical